SETD2 loss-of-function uniquely sensitizes cells to epigenetic targeting of NSD1-directed H3K36 methylation

Abstract Background SETD2 is the sole epigenetic factor responsible for catalyzing histone 3, lysine 36, tri-methylation (H3K36me3) in mammals. Its role in regulating cellular processes such as RNA splicing, DNA repair, and spurious transcription initiation underlies its broader tumor suppressor fun...

Full description

Bibliographic Details
Published in:Genome Biology
Main Authors: Ryan T. Wagner, Ryan A. Hlady, Xiaoyu Pan, Liguo Wang, Sungho Kim, Xia Zhao, Louis Y. El Khoury, Shafiq Shaikh, Jian Zhong, Jeong-Heon Lee, Jolanta Grembecka, Tomasz Cierpicki, Thai H. Ho, Keith D. Robertson
Format: Article
Language:English
Published: BMC 2025-02-01
Subjects:
Clear cell renal cell carcinoma (ccRCC)
SETD2
Histone 3, lysine 36, tri-methylation (H3K36me3)
NSD1
Synthetic lethality (SL)
CRISPRi
Online Access:https://doi.org/10.1186/s13059-025-03483-z

Internet

https://doi.org/10.1186/s13059-025-03483-z

Similar Items